Oxford Immunotec to Present at the Baird 2017 Global Healthcare Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass., August 30, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Rick Altieri, Chief Financial Officer, will present at the Baird 2017 Global Healthcare Conference on Wednesday, September 6, 2017, at 2:35 p.m. ET at the InterContinental New York Barclay Hotel in New York, NY.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company's first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company's second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Also obtained through the acquisitions is the Company's third product line focused on screening for Babesia in donated blood, for which the Company is currently seeking FDA licensure. The T-SPOT.CMV test and the T-SPOT.PRT test are pipeline products as part of the Company's fourth intended product line focused on the transplantation market. In addition to these four product lines, the Company has additional active development programs in other immune-regulated conditions. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. Additional information can be found at www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. Immunetics is a trademark of Immunetics, Inc.
For Media and Investor Inquiries:
Head of Strategy and Investor Relations
Tel: +1 (508) 556-1377
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Oxford Immunotec via Globenewswire
Följ NASDAQ OMX
Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.
Senaste pressmeddelandena från NASDAQ OMX
NTT Security Launches Security Services for Industrial Control Systems20.9.2017 10:00 | Pressmeddelande
Cyber-defense for critical infrastructure including factories, plants, utilities & hospitals TOKYO, Sept. 20, 2017 (GLOBE NEWSWIRE) -- NTT Security Corporation (Head Office: Chiyoda-Ku, Tokyo; CEO: Jun Sawada), the specialized security company of NTT Group, has launched "IT/OT Integrated Security Services". The new services will be taken to market globally through the NTT Group companies, Dimension Data, NTT Communications and NTT DATA, forming part of its suite of integrated services to enable successful digital transformation initiatives for its clients. Companies are increasingly working towards IT/OT (Operational Technology) alignment. OT systems, when connected to the internet, streamline business operations by advanced supply chain management, realization of mass customization and improvement of customer experience as well as find new intelligence employing IoT (the Internet of Things) and Big Data analytics. As a result, IT/OT convergence is ex
NTT Security lanserar säkerhetstjänster för industriella styrsystem20.9.2017 10:00 | Pressmeddelande
Cyberförsvar för kritisk infrastruktur, bland annat fabriker, anläggningar, försörjningssystem och sjukhus STOCKHOLM, 20 september 2017 (GLOBE NEWSWIRE) -- NTT Security Corporation, (huvudkontor: Chiyoda-Ku, Tokyo; CEO: Jun Sawada) det specialiserade säkerhetsföretaget inom NTT Group, lanserar IT/OT-integrerade säkerhetstjänster. De nya tjänsterna kommer att lanseras på den globala marknaden genom företag som ingår i NTT Group, nämligen Dimension Data, NTT Communications och NTT DATA. De kommer att ingå i ett erbjudande med integrerade tjänster som möjliggör en framgångsrik digital omvandling för företagets kunder. Företag arbetar alltmer med att sammanlänka IT och OT-system (IT-system för processtyrning) som gör att företagsverksamheter kan ansluts till internet. Detta sker genom en avancerad hantering av leveranskedjan, realisering av masskundanpassning och en förbättrad kundupplevelse. De införskaffar även ny information och underrättelser genom tillämpning av IoT (sak
Zumio(TM) Now Available in Europe20.9.2017 08:00 | Pressmeddelande
Exclusive Partnership Agreement Signed with Eropartner Distribution Ottawa, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zumio Inc. proudly announces it has partnered exclusively with Eropartner Distribution for distribution across all 28 EU member countries. Winner of the Best New Product at ADULTEX 2017, Zumio is the world's only clitoral stimulator based on the proven circular fingertip motion. Zumio's patented SpiroTIP(TM) and motor clutch drive system allows users to dynamically go from high speed and intensity down to a low speed and intensity, without having to touch a control, to instinctively and more naturally, adjust the stimulation to suit their needs. "Traditional vibrators generate excess energy and shake everything they touch often creating sensory overload and a numbing effect," said Steve Traplin, Chief Revenue Officer at Zumio. " Our non-vibrating technology makes Zumio more comfortable to hold and the small TIP and
Juniper Systems Limited Eyes German Market with InterGeo 2017 Exhibit, Opens New Office in Wels, Austria20.9.2017 04:16 | Pressmeddelande
BIRMINGHAM, United Kingdom, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Manufacturer of rugged handheld data collectors Juniper Systems Limited aims to expand its footprint in the German marketplace. Coinciding with the opening of its new office in Wels, Austria, the company will exhibit at the geometrics industry trade fair, InterGeo 2017, next week in Berlin, Germany. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ec8e4e2c-b277-48f9-bce9-4606d17454a5 The Wels location was recently opened to serve German-speaking partners and customers in Austria, Germany, and other Eastern European countries. Juniper Systems will showcase its ultra-rugged solutions for GIS, geomatics and geoinformation applications in Hall 1.1 on Stand C1.010 on 26 - 28 September at InterGeo. 'We're excited to be exhibiting at the InterGeo trade fair, which is now a regular date in our diary', commented Simon Bowe, general manager of Juni
CallidusCloud Unveils Game-Changing Augmented Intelligence Platform for Sales Performance, Execution and Learning Customers19.9.2017 22:35 | Pressmeddelande
Thunderbridge AI³ Combines the Power of Artificial Intelligence, Application Integration, and Human Insight to Provide Contextual Augmented Intelligence Recommendations throughout the Lead to Money suite DUBLIN, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, unveiled its newest platform, Thunderbridge Augmented Intelligence - or Thunderbridge AI³ - today at CallidusCloud Connections (C3) 2017, its annual user conference. The new solution is comprised of three elements: artificial intelligence, application integration, and human insight. The Thunderbridge Augmented Intelligence platform is a layer of software that applies machine learning techniques to the sales and learning processes to come up with recommended actions for increasing revenue, profit, and sales effectiveness. The role of human insight and behavior is key to Thunderbridge AI
Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference19.9.2017 22:05 | Pressmeddelande
GAITHERSBURG, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference. Presentation details are as follows: Date: Tuesday, September 26, 2017 Time: 11:00 - 11:25 am ET Location: Track 5, Montmartre, Sofitel Hotel, New York City Live webcast: www.novavax.com, "Investors"/"Events" A replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com. About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional inf
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum